Results 191 to 200 of about 17,995 (248)

Reply to "Reconsidering dopaminergic modulation in Alzheimer's disease: A case for levodopa/carbidopa as a disease-modifying agent". [PDF]

Alzheimers Dement
Sárkány Z, Damásio J, Macedo-Ribeiro S, Martins PM.   +3 more
europepmc   +1 more source

Levodopa-carbidopa intestinal gel (LCIG) treatment in routine care of patients with advanced Parkinson’s disease: An open-label prospective observational study of effectiveness, tolerability and healthcare costs

, 2016
Sven Pålhagen, Olof Sydow, Anders Johansson, Dag Nyholm, Björn Holmberg, Håkan Widner, Nil Dizdar, Jan Linder, Tove Hauge, Rasmus Jansson‐Löfmark, Lars Bergmann, Susanna Kjellander, Thomas S. Marshall   +12 more
openalex   +1 more source

Minimal clinically important difference on Parkinson's Disease Sleep Scale 2nd version (PDSS-2) [PDF]

, 2015
Aschermann, Zsuzsanna, Deli, Gabriella, Horváth, Krisztina, Janszky, József, Kovács, Norbert, Ács, Péter   +5 more
core  

Reduced Plasma Levodopa Fluctuations with More Frequent Administration of a Novel Carbidopa/Levodopa Functionally Scored Tablet [PDF]

Thomas N. Chase, Ahmad Al‐Sabbagh, Minako Koga, Kathleen Clarence‐Smith   +3 more
openalex   +1 more source

Development of an in-situ forming implant system for levodopa and carbidopa for the treatment of parkinson's disease. [PDF]

Drug Deliv Transl Res
Nakmode DD, Abdella S, Song Y, Garg S.
europepmc   +1 more source

Othello Syndrome Induced by Dopamine Agonists in Parkinson's Disease: A Case Report. [PDF]

Case Rep Psychiatry
Ahmed GU, Ahmed HU, Raza AA, Samadi A.
europepmc   +1 more source

Levodopa Intestinal Gel Infusion Therapies in Advanced Parkinson's Disease: A Swedish Study on Real-World Use and Costs. [PDF]

Neurol Ther
Odin P, Tærud C, Samuelsson J, Sabelström E, Lagerlund J, Freilich J, Stelmaszuk MN.   +6 more
europepmc   +1 more source

Therapieerfahrungen mit der pumpengesteuerten enteralen Infusion eines Levodopa/Carbidopa-Gels bei fortgeschrittenem Morbus Parkinson

, 2011
,
openalex   +1 more source

The role of gut microbiota tyrosine decarboxylases in levodopa pharmacokinetics: insights from a levodopa challenge test. [PDF]

BMC Neurol
Feng Y, Zhang R, Wen G, Xie L, Chen T, Liu W.   +5 more
europepmc   +1 more source

Cost of Quality of Life in Advanced Parkinson's Disease: Efficient Strategies for Disease Assessment. [PDF]

Rev Neurol
García-Agua Soler N, García Trujillo L, García-Ruiz AJ.   +2 more
europepmc   +1 more source